Physician profile

Vonda J Wright

Sports Medicine (Orthopaedic Surgery) · Orlando, FL

NPI 1023053063

$13,346.99

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$5,973.77
Food and Beverage$722.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Reel Surgical, INC. $7,820.34 2021-2024
Arthrex, INC. $3,970.51 2021-2024 Arthrex
Stryker Corporation $800.53 2019-2022
United Orthopedics LLC $442.00 2020
Zimmer Biomet Holdings, INC. $122.84 2021
Vericel Corporation $119.03 2019
Horizon Therapeutics Plc $38.05 2019-2020
Hydrocision, INC. $22.53 2019
Janssen Pharmaceuticals, INC $11.16 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vonda J Wright

$13,346.99

in general payments reported 2019-2025

Years
2019-2024
Top company
Reel Surgical, INC.

https://glasscript.com/doctor/1047280/vonda-j-wright

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.